Coronavirus (COVID-19)—implications for structured products and securitisation transactions
Coronavirus (COVID-19)—implications for structured products and securitisation transactions

The following Banking & Finance practice note provides comprehensive and up to date legal information covering:

  • Coronavirus (COVID-19)—implications for structured products and securitisation transactions
  • Coronavirus (COVID-19)
  • Issues affecting securitisations
  • Securitisation Regulation—reporting
  • Securitisation Regulation—monitoring
  • MAC clauses and force majeure
  • Specific issues relating to CLOs
  • New transactions—timetables, signing and settlement
  • Noteholder meetings
  • Practical tips for securitisation lawyers
  • More...

IP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the UK’s withdrawal from the EU. At this point in time (referred to in UK law as ‘IP completion day’), key transitional arrangements come to an end and significant changes begin to take effect across the UK’s legal regime. This document contains guidance on subjects impacted by these changes. Before continuing your research, see Practice Note: What does IP completion day mean for lending lawyers? [Archived].

This Practice Note discusses the implications of the coronavirus (COVID-19) outbreak for structured products and securitisation transactions and includes practical tips for lawyers working in these areas. For regular updates of news and analysis on the outbreak relevant to structured products and securitisation transactions, see Practice Note: Coronavirus (COVID-19) implications for Banking & Finance lawyers.

Coronavirus (COVID-19)

Lawyers across the world are currently grappling with many common areas of concern in connection with the coronavirus (COVID-19) pandemic. The Coronavirus (COVID-19) toolkit has been created to assist lawyers with easy access to news, practical guidance and Q&As from across a number of practice areas that relate to these key areas of concern. In addition to coronavirus-specific content, the toolkit also highlights additional guidance and support materials of general relevance to each of these areas.

There are a number of areas that are particularly

Related documents:

Popular documents